TITLE

Study cites importance of patient self-reports

PUB. DATE
February 2010
SOURCE
Clinical Trials Administrator;Feb2010, Vol. 8 Issue 2, p15
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article discusses research in the importance of self-reports in collecting data for adverse events. It references the study "Adverse Symptom Event Reporting by Patients vs Clinicians: Relationships With Clinical Outcomes," by Ethan M. Basch et al and published in a 2009 issue of the "Journal of the National Cancer Institute." The study found that reports by patient offer better review of daily health status.
ACCESSION #
47841043

 

Related Articles

  • Patient self reporting for CR is trend expected to grow.  // Clinical Trials Administrator;Feb2010, Vol. 8 Issue 2, p17 

    The article discusses research in the importance of self-reports in collecting data for adverse events. It references the study "Adverse Symptom Event Reporting by Patients vs Clinicians: Relationships With Clinical Outcomes," by Ethan M. Basch et al and published in a 2009 issue of the "Journal...

  • Post-hospital syndrome in adults with asthma: a case-crossover study. Sadatsafavi, Mohsen; Lynd, Larry D.; FitzGerald, Mark // Allergy, Asthma & Clinical Immunology;2013, Vol. 9 Issue 1, p31 

    Background Post-hospital syndrome refers to the period of generalized risk of adverse health outcomes among patients who are recently discharged from hospital. This period is associated with a short-term increased risk of readmission which may not be related to the original condition. While the...

  • Refining the definition of clinically important mineral and bone disorder in hemodialysis patients. Danese, Mark D.; Halperin, Marc; Lowe, Kimberly A.; Bradbury, Brian D.; Do, Thy P.; Block, Geoffrey A. // Nephrology Dialysis Transplantation;Aug2015, Vol. 30 Issue 8, p1336 

    Background. It is important to identify an easily defined subset of patients at increased risk of adverse clinical outcomes associated with mineral and bone disorder (MBD) biomarkers (parathyroid hormone, calcium and phosphate). Methods. Observational cohort study of 26 221 prevalent...

  • Number Needed To... $ave? Rocker, Graeme M.; Verma, Jennifer Y.; Demmons, Jillian; Mittmann, Nicole // Clinical & Investigative Medicine;Feb2015, Vol. 38 Issue 1, pE11 

    The 'Number Needed to Treat' (NNT) is a useful measure for estimating the number of patients that would need to receive a therapeutic intervention to avoid one of the adverse events that the treatment is designed to prevent. We explored the possibility of an adaption of NNT to estimate the...

  • Study ranks patient safety at Chicago-area hospitals. MAROTTI, ALLY // Crain's Chicago Business;10/26/2015, Vol. 38 Issue 43, p0019 

    The article focuses on an annual study by Denver, Colorado-based research company Healthgrades, which revealed that outcomes on the same treatment can vary from one hospital to another. Noted is the use of a model which examined complication and mortality rates at hospitals across the U.S. Also...

  • CNE/CME questions.  // Clinical Trials Administrator;Feb2010, Vol. 8 Issue 2, p24 

    A quiz about topics in this issue is presented, which includes adverse events, self reporting of outcome by patients and biosketch.

  • Prognostic predictors and outcomes in patients with abnormal myocardial perfusion imaging and angiographically insignificant coronary artery disease Alqaisi, Fadi; AlBadarin, Firas; Jaffery, Zehra; Tzogias, Leonidas; Dawod, Muath; Jacobsen, Gordon; Ananthasubramaniam, Karthik // Journal of Nuclear Cardiology;Nov2008, Vol. 15 Issue 6, p754 

    Background: Abnormal stress myocardial perfusion imaging studies (SMPI) with angiographically insignificant coronary artery disease (ICAD) have often been labeled “false positive” scans. We evaluated the prognostic predictors and outcomes in an unselected patient population having...

  • Erythropoiesis-stimulating agents for the treatment of chemotherapy-induced anemia: comparisons from real-world clinical experience. Garzotto, Analia Rodriguez; Heine, Oliver; Turner, Matthew; Laserna, Francisco Rebollo; Lorenz, Andreas // Journal of Blood Medicine;2014, Vol. 5, p43 

    Background: The purpose of this paper is to report real-world data on the relative effectiveness of a biosimilar erythropoiesis-stimulating agent (ESA; Binocrit®), and other available ESAs for the treatment of chemotherapy-induced anemia. Methods: Data were collected retrospectively from...

  • Tiotropium in patients with moderate COPD naive to maintenance therapy: a randomised placebo-controlled trial. Troosters, Thierry; Sciurba, Frank C.; Decramer, Marc; Siafakas, Nikos M.; Klioze, Solomon S.; Sutradhar, Santosh C.; Weisman, Idelle M.; Yunis, Carla // Primary Care Respiratory Society UK;6/1/2014, p1 

    BACKGROUND: The benefits of pharmacotherapy with tiotropium HandiHaler 18 μg for patients with chronic obstructive pulmonary disease (COPD) have been previously demonstrated. However, few data exist regarding the treatment of moderate disease (Global Initiative for Chronic Obstructive Lung...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics